Vitronectin

Vitronectin Molekülinformation

Englischer Name	Vitronectin	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	0	Target-Alias	Vitronectin，V75，VN，Serum-spreading factor，Vitronectin (Serum Spreading Factor， Somatomedin B， Complement S-Protein)，Somatomedin B，Epibolin，Serum Spreading Factor，VNT，S-protein，Complement S-Protein，Protein S
Höchste Forschungs- und Entwicklungsphase	Preclinical

Englischer Name	Vitronectin
Target-Alias	Vitronectin，V75，VN，Serum-spreading factor，Vitronectin (Serum Spreading Factor， Somatomedin B， Complement S-Protein)，Somatomedin B，Epibolin，Serum Spreading Factor，VNT，S-protein，Complement S-Protein，Protein S
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	0
Höchste Forschungs- und Entwicklungsphase	Preclinical

Vitronectin Produktliste

Attribut
Protein (4)Kits (1)
Produktbibliothek
Online (5)
Spezies
Human (5)
Etikett
Tag Free (4)- (1)
Marker
Unconjugated (4)- (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
GMP-VINH19	Human	E. coli	GMP Human Truncated Vitronectin / VTN-N Protein	In den Warenkorb legen
RES-A103	Human	-	resDetect™ Vitronectin ELISA Kit (Residue Testing)	In den Warenkorb legen
VIN-H5117	Human	E. coli	Human Truncated Vitronectin / VTN-N Protein, premium grade	In den Warenkorb legen
VIN-H5118	Human	E. coli	Human Truncated Vitronectin / VTN-N Protein, Research Grade	In den Warenkorb legen
VIN-H5214	Human	HEK293	Human Vitronectin / VTN Protein, Tag Free, low endotoxin	In den Warenkorb legen

Gesamtmenge5

Vitronectin Molekülhintergrund

Vitronectin is also known as S-protein, VN, VTN, V75. Vitronectin, a multifunctional glycoprotein, is involved in coagulation, inhibition of the formation of the membrane attack complex (MAC), cell adhesion and migration, wound healing, and tissue remodeling. The primary cellular source of vitronectin is hepatocytes. Blocking of Hic(a member of the pneumococcal surface protein C (PspC) family) by specific antiserum or genetic deletion significantly reduced pneumococcal binding to soluble and immobilised vitronectin and to Factor H, respectively. In addition, Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.